Developing Gene Therapy for Cystic Fibrosis and Other Respiratory Diseases

29 Jan 2026
Advanced Therapies Stage

 

  • Rationale for inhaled gene therapy in cystic fibrosis and other respiratory diseases: therapeutic goals and unmet need 

  • Key considerations for vector development and preclinical testing 

  • Complexities of lung gene therapy 

Speakers
Uta Griesenbach
Uta Griesenbach, Professor of Molecular Medicine - Imperial College London